HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer

被引：0
|
作者：
Luciana de Moura Leite
Marcelle Goldner Cesca
Monique Celeste Tavares
Debora Maciel Santana
Erick Figueiredo Saldanha
Paula Tavares Guimarães
Daniella Dias Silva Sá
Maria Fernanda Evangelista Simões
Rafael Lima Viana
Francisca Giselle Rocha
Simone Klog Loose
Sinara Figueiredo Silva
Rafaela Pirolli
Camilla Albina Zanco Fogassa
Bruna Raphaeli Silva Mattos
Fernando Augusto Batista Campos
Solange Moraes Sanches
Vladmir Cláudio Cordeiro de Lima
Noam Falbel Pondé
机构：
[1] A.C. Camargo Cancer Center,Department of Medical Oncology
来源：
Breast Cancer Research and Treatment | 2021年 / 190卷
关键词：
HER2; HER2-low breast cancer; Antibody–drug conjugates; Trastuzumab–deruxtecan; Trastuzumab–duocarmazine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：155 / 163
页数：8
相关论文
共 50 条
  • [1] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
    de Moura Leite, Luciana
    Cesca, Marcelle Goldner
    Tavares, Monique Celeste
    Santana, Debora Maciel
    Saldanha, Erick Figueiredo
    Guimaraes, Paula Tavares
    Sa, Daniella Dias Silva
    Simoes, Maria Fernanda Evangelista
    Viana, Rafael Lima
    Rocha, Francisca Giselle
    Loose, Simone Klog
    Silva, Sinara Figueiredo
    Pirolli, Rafaela
    Fogassa, Camilla Albina Zanco
    Mattos, Bruna Raphaeli Silva
    Campos, Fernando Augusto Batista
    Sanches, Solange Moraes
    de Lima, Vladmir Claudio Cordeiro
    Ponde, Noam Falbel
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 190 (01) : 155 - 163
  • [2] Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy
    Ilie, Silvia Mihaela
    Briot, Nathalie
    Constantin, Guillaume
    Roussot, Nicolas
    Ilie, Alis
    Bergeron, Anthony
    Arnould, Laurent
    Beltjens, Francoise
    Desmoulin, Isabelle
    Mayeur, Didier
    Kaderbhai, Coureche
    Hennequin, Audrey
    Jankowski, Clementine
    Padeano, Marie Martine
    Costaz, Helene
    Amet, Alix
    Coutant, Charles
    Coudert, Bruno
    Bertaut, Aurelie
    Ladoire, Sylvain
    BREAST CANCER, 2023, 30 (06) : 997 - 1007
  • [3] Improving HER2 testing reproducibility in HER2-low breast cancer
    Sajjadi, Elham
    Venetis, Konstantinos
    Ivanova, Mariia
    Fusco, Nicola
    CANCER DRUG RESISTANCE, 2022, 5 (04) : 882 - 888
  • [4] Impact of Human Epidermal Growth Factor Receptor 2 (HER2) Low Status in Response to Neoadjuvant Chemotherapy in Early Breast Cancer
    Alves, Fatima R.
    Gil, Lucia
    de Matos, Leonor Vasconcelos
    Baleiras, Ana
    Vasques, Carolina
    Neves, Maria Teresa
    Ferreira, Andre
    Fontes-Sousa, Mario
    Miranda, Helena
    Martins, Ana
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [5] Alteration of HER2 Status During Breast Cancer Progression: A Clinicopathological Analysis Focusing on HER2-Low Status
    Bai, Kyungah
    Woo, Ji Won
    Kwon, Hyun Jung
    Chung, Yul Ri
    Suh, Koung Jin
    Kim, Se Hyun
    Kim, Jee Hyun
    Park, So Yeon
    LABORATORY INVESTIGATION, 2024, 104 (08)
  • [6] Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy according to HER2-low status
    Raghavendra, A. S.
    Zakon, D. B.
    Jin, Q.
    Strahan, A.
    Grimm, M.
    Hughes, M. E.
    Cherian, M.
    Vincuilla, J.
    Parker, T.
    Tarantino, P.
    Mittendorf, E. A.
    King, T. A.
    Valero, V.
    Tripathy, D.
    Tolaney, S. M.
    Tayob, N.
    Lin, N. U.
    Stover, D. G.
    Barcenas, C. H.
    Garrido-Castro, A. C.
    ESMO OPEN, 2024, 9 (11)
  • [7] Influence of Neoadjuvant Chemotherapy on HER2/neu Status in Invasive Breast Cancer
    Li, Peifeng
    Liu, Tantan
    Wang, Yingmei
    Shao, Shuai
    Zhang, Weichen
    Lv, Yang
    Yi, Jun
    Wang, Zhe
    CLINICAL BREAST CANCER, 2013, 13 (01) : 53 - 60
  • [8] HER2 categorical changes after neoadjuvant chemotherapy: A study of 192 matched breast cancers with the inclusion of HER2-Low category
    Karakas, Cansu
    Tyburski, Haley
    Weiss, Anna
    Akkipeddi, Sajal Medha K.
    Dhakal, Ajay
    Skinner, Kristin
    Zhang, Huina
    HUMAN PATHOLOGY, 2023, 142 : 34 - 41
  • [9] HER2 and response to anthracycline-based neoadjuvant chemotherapy in breast cancer
    Yao, L.
    Liu, Y.
    Li, Z.
    Ouyang, T.
    Li, J.
    Wang, T.
    Fan, Z.
    Fan, T.
    Lin, B.
    Xie, Y.
    ANNALS OF ONCOLOGY, 2011, 22 (06) : 1326 - 1331
  • [10] HER2 immunohistochemistry staining positivity is strongly predictive of tumor response to neoadjuvant chemotherapy in HER2 positive breast cancer
    Zhao, Jing
    Krishnamurti, Uma
    Zhang, Chao
    Meisel, Jane
    Wei, Zhimin
    Suo, Aili
    Aneja, Ritu
    Li, Zaibo
    Li, Xiaoxian
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (11)
12345